Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection.
Zhou, Hui-Jun; Wu, Gang; Li, Ji-Ming; Naidoo, Nasheen; Xie, Yan-Xiang; Feng, Bo-Lan; Wang, Pei; Luo, Ji-Wei.
Afiliação
  • Zhou HJ; Department of Public Administration, Business School, University of Shanghai for Science & Technology, Shanghai, China.
  • Wu G; Department of Medical Records, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
  • Li JM; Department of Experimental Center, Business School, University of Shanghai for Science & Technology, Shanghai, China; .
  • Naidoo N; Department of Pathology, Stellenbosch University, Cape Town, South Africa.
  • Xie YX; Department of Infectious Disease, The 79th group army hospital of PLA, Liaoyang, China.
  • Feng BL; Department of Public Administration, Business School, University of Shanghai for Science & Technology, Shanghai, China.
  • Wang P; Key Lab of Health Technology Assessment, National Health Commission of the People's Republic of China (Fudan University), Shanghai, China; School of Public Health, Fudan University, Shanghai, China.
  • Luo JW; Department of Orthopedics, Zengcheng Branch, Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
Ann Palliat Med ; 10(10): 10313-10326, 2021 10.
Article em En | MEDLINE | ID: mdl-34670381

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Ann Palliat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Ann Palliat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China